$91.04
0.04%
NYSE, Nov 28, 10:00 pm CET
ISIN
US3795772082
Symbol
GMED

Globus Medical, Inc. Class A Target price 2025 - Analyst rating & recommendation

Globus Medical, Inc. Class A Classifications & Recommendation:

Buy
62%
Hold
38%

Globus Medical, Inc. Class A Price Target

Target Price $91.80
Price $91.04
Potential
Number of Estimates 14
14 Analysts have issued a price target Globus Medical, Inc. Class A 2026 . The average Globus Medical, Inc. Class A target price is $91.80. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 21 analysts: 13 Analysts recommend Globus Medical, Inc. Class A to buy, 8 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Globus Medical, Inc. Class A stock has an average upside potential 2026 of . Most analysts recommend the Globus Medical, Inc. Class A stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 2.52 2.91
60.62% 15.58%
EBITDA Margin 13.69% 28.30%
15.07% 106.67%
Net Margin 4.09% 15.11%
47.82% 269.66%

17 Analysts have issued a sales forecast Globus Medical, Inc. Class A 2025 . The average Globus Medical, Inc. Class A sales estimate is

$2.9b
Unlock
. This is
5.13% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.0b 9.21%
Unlock
, the lowest is
$2.8b 0.66%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $2.5b 60.62%
2025
$2.9b 15.58%
Unlock
2026
$3.1b 7.97%
Unlock
2027
$3.4b 6.55%
Unlock
2028
$3.5b 4.36%
Unlock

14 Analysts have issued an Globus Medical, Inc. Class A EBITDA forecast 2025. The average Globus Medical, Inc. Class A EBITDA estimate is

$824m
Unlock
. This is
37.40% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$912m 52.11%
Unlock
, the lowest is
$701m 16.90%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $345m 36.42%
2025
$824m 138.91%
Unlock
2026
$921m 11.80%
Unlock
2027
$1.0b 10.37%
Unlock
2028
$1.1b 10.91%
Unlock

EBITDA Margin

2024 13.69% 15.07%
2025
28.30% 106.67%
Unlock
2026
29.31% 3.57%
Unlock
2027
30.36% 3.58%
Unlock
2028
32.27% 6.29%
Unlock

16 Globus Medical, Inc. Class A Analysts have issued a net profit forecast 2025. The average Globus Medical, Inc. Class A net profit estimate is

$440m
Unlock
. This is
3.84% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$461m 8.73%
Unlock
, the lowest is
$416m 1.94%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $103m 16.19%
2025
$440m 327.33%
Unlock
2026
$501m 13.74%
Unlock
2027
$568m 13.39%
Unlock
2028
$660m 16.37%
Unlock

Net Margin

2024 4.09% 47.82%
2025
15.11% 269.66%
Unlock
2026
15.92% 5.36%
Unlock
2027
16.94% 6.41%
Unlock
2028
18.89% 11.51%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.75 3.27
29.91% 336.00%
P/E 27.85
EV/Sales 4.07

16 Analysts have issued a Globus Medical, Inc. Class A forecast for earnings per share. The average Globus Medical, Inc. Class A EPS is

$3.27
Unlock
. This is
4.81% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$3.42 9.62%
Unlock
, the lowest is
$3.09 0.96%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.75 29.91%
2025
$3.27 336.00%
Unlock
2026
$3.72 13.76%
Unlock
2027
$4.22 13.44%
Unlock
2028
$4.91 16.35%
Unlock

P/E ratio

Current 29.18 77.27%
2025
27.85 4.56%
Unlock
2026
24.48 12.10%
Unlock
2027
21.59 11.81%
Unlock
2028
18.56 14.03%
Unlock

Based on analysts' sales estimates for 2025, the Globus Medical, Inc. Class A stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.28 19.55%
2025
4.07 4.80%
Unlock
2026
3.77 7.38%
Unlock
2027
3.54 6.15%
Unlock
2028
3.39 4.18%
Unlock

P/S ratio

Current 4.42 18.39%
2025
4.21 4.88%
Unlock
2026
3.90 7.38%
Unlock
2027
3.66 6.15%
Unlock
2028
3.51 4.18%
Unlock

Current Globus Medical, Inc. Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Truist Securities
Locked
Locked
Locked Nov 18 2025
Barclays
Locked
Locked
Locked Nov 10 2025
B of A Securities
Locked
Locked
Locked Nov 07 2025
Truist Securities
Locked
Locked
Locked Nov 07 2025
Wells Fargo
Locked
Locked
Locked Nov 07 2025
RBC Capital
Locked
Locked
Locked Nov 07 2025
Stifel
Locked
Locked
Locked Oct 28 2025
Analyst Rating Date
Locked
Truist Securities:
Locked
Locked
Nov 18 2025
Locked
Barclays:
Locked
Locked
Nov 10 2025
Locked
B of A Securities:
Locked
Locked
Nov 07 2025
Locked
Truist Securities:
Locked
Locked
Nov 07 2025
Locked
Wells Fargo:
Locked
Locked
Nov 07 2025
Locked
RBC Capital:
Locked
Locked
Nov 07 2025
Locked
Stifel:
Locked
Locked
Oct 28 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today